Wednesday, May 4, 2016

BRIEF-FDA grants priority review for Lilly's Olaratumab

* FDA grants priority review for lilly's Olaratumab, an

investigational medicine for advanced soft tissue sarcoma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)